GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (NSE:SANOFI) » Definitions » Additional Paid-In Capital

Sanofi India (NSE:SANOFI) Additional Paid-In Capital : ₹20 Mil(As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Sanofi India Additional Paid-In Capital?


Sanofi India's quarterly additional paid-in capital stayed the same from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹0 Mil) but then increased from Sep. 2023 (₹0 Mil) to Dec. 2023 (₹20 Mil).

Sanofi India's annual additional paid-in capital stayed the same from Dec. 2021 (₹20 Mil) to Dec. 2022 (₹20 Mil) and stayed the same from Dec. 2022 (₹20 Mil) to Dec. 2023 (₹20 Mil).


Sanofi India Additional Paid-In Capital Historical Data

The historical data trend for Sanofi India's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Additional Paid-In Capital Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.00 20.00 20.00 20.00 20.00

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.00 - - - 20.00

Sanofi India Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sanofi India Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sanofi India's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (NSE:SANOFI) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (NSE:SANOFI) Headlines

No Headlines